title: Inhaled nitric oxide and inhibition of platelet aggregation in critically ill neonates.
authors.forename: P Y
authors.initials: PY
authors.lastname: Cheung
authors.forename: E
authors.initials: E
authors.lastname: Salas
authors.forename: P C
authors.initials: PC
authors.lastname: Etches
authors.forename: E
authors.initials: E
authors.lastname: Phillipos
authors.forename: R
authors.initials: R
authors.lastname: Schulz
authors.forename: M W
authors.initials: MW
authors.lastname: Radomski
mesh_terms: D000280:Administration, Inhalation; D001760:Bleeding Time; D005260:Female; D006801:Humans; D007231:Infant, Newborn; D015931:Intensive Care, Neonatal; D008297:Male; D009569:Nitric Oxide / Q000008:administration & dosage / Q000009:adverse effects*; D010974:Platelet Aggregation / Q000187:drug effects*; D012121:Respiration, Artificial; D012127:Respiratory Distress Syndrome, Newborn / Q000097:blood / Q000188:drug therapy*
chemical_list: D009569:Nitric Oxide